Publication | Closed Access

Selective Inhibition of Endothelin Receptor A as an Anti-angiogenic and Anti-proliferative Strategy for Human Pancreatic Cancer

Anti-proliferative StrategyPancreatic CancerChemoprevention StrategyMedicinePathologyHuman Pancreatic CancerVascular BiologyPharmacologyEndothelin Receptor ATumor MicroenvironmentCancer Research